Home-Based Exercise for Adults Living With Overweight and Obesity

Официальное название

WE Are Active and In This toGetHer (WEIGH): a Randomised Controlled Trial to Ascertain the Feasibility of a Home-based Exercise Programme for People Living With Overweight and Obesity

Обзор

The study aims to implement a 12-week home-based exercise programme utilising an online intervention delivery platform. The focus will be on increasing exercise behaviour within the participant's home setting using aerobic, resistance and flexibility exercises as well as behaviour change techniques. Following the programme, semi-structured interviews will be conducted, to explore participant experiences. It is hypothesised that the exercise programme will be feasible, accessible and acceptable.

Вмешательства

• Поведенческое Home-based exercise programme
  A 12 week, online delivered, home-based exercise programme.

Первичные конечные точки

• Feasibility and acceptability of the programme through recruitment rate [Срок оценки: Calculated at trial end, i.e.12 weeks after inclusion.]
• Feasibility and acceptability of the programme through attrition [Срок оценки: Calculated at trial end, i.e. 12 weeks after inclusion.]
• Feasibility and acceptability of the programme through adherence [Срок оценки: Calculated at trial end, i.e. 12 weeks after inclusion.]
• Feasibility and acceptability of the programme through intervention engagement [Срок оценки: Calculated at trial end, i.e. 12 weeks after inclusion.]
• Feasibility and acceptability of the programme through completion rate [Срок оценки: Calculated at trial end, i.e. 12 weeks after inclusion.]
• Acceptability and experience of the programme via participant interviews [Срок оценки: Evaluated after intervention period, i.e. up to 12 weeks after inclusion offer.]

Вторичные конечные точки (7)

• Participant Body Mass (kg) [Срок оценки: Taken at baseline, 6 weeks and 12 weeks/programme completion.]
• Participant Body Fat Mass (kg) [Срок оценки: Taken at baseline, 6 weeks and 12 weeks/programme completion.]
• Participant Body Fat Percentage (%) [Срок оценки: Taken at baseline, 6 weeks and 12 weeks/programme completion.]
• Participant Fat Free Mass (%) [Срок оценки: Taken at baseline, 6 weeks and 12 weeks/programme completion.]
• Participant Body Mass Index (kg/m^2) [Срок оценки: Taken at baseline, 6 weeks and 12 weeks/programme completion.]
• Participant waist to hip ratio [Срок оценки: Taken at baseline, 6 weeks and 12 weeks/programme completion.]
• Participant resting blood pressure (mmHg) [Срок оценки: Taken at baseline, 6 weeks and 12 weeks/programme completion.]

Критерии участия

Критерии включения

• BMI ≥25kg/m² or BMI ≥30kg/m²
• English speaking
• Able to follow visual and verbal instructions
• Access to the internet and accompanying technology (e.g. laptop or tablet)
• Physically able to undertake aerobic, resistance and flexibility exercise

Критерии исключения

• Unable to provide informed consent
• Receiving invasive medical treatment or planned surgery preceding to, or during, the programme
• Severe mental or physical limitations precluding participation safely in the home environment
• No access to the internet and/or facilitative technology such as a laptop or tablet
• Pregnancy
• Current smoker or vaping.
• Currently or very recently stopped taking weight loss medication (within the last two weeks)
• Recently experienced substantial weight change (defined as 5% within 6-12 months)
• Presence of contraindications to exercise
• Pacemaker and/or other implanted metal device
• At high risk of cardiovascular event

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Открытое

Основная цель

Лечение

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Идентификаторы

NCT: NCT05807386 · P149993

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗